Emmet McCormack
Impact in
Papers in
-
- Histone Deacetylase Inhibitors Research 11
- Protein Degradation and Inhibitors 8
- Oncology 28
- Cancer Cells and Metastasis 10
- Co-authors
- Bjørn Tore Gjertsen (48 shared papers)Øystein Bruserud (20 shared papers)Spiros Kotopoulis (13 shared papers)Odd Helge Gilja (11 shared papers)Mihaela Popa (23 shared papers)David Micklem (7 shared papers)James B. Lorens (6 shared papers)Rolf Bjerkvig (3 shared papers)
- Journals
- PLoS ONE (7 papers)Blood (6 papers)Pharmaceutics (5 papers)Cancers (5 papers)Cancer Research (5 papers)
- Partner nations
- NorwayUnited StatesNetherlands
In The Last Decade
Emmet McCormack
88 papers receiving 3.1k citations
Emmet McCormack's Hit Papers
Peers
Comparison fields: 5 of 116
- Genetics 419
- Oncology 835
- Immunology 529
- Cancer Research 361
- Hematology 233
Countries citing papers authored by Emmet McCormack
This map shows the geographic impact of Emmet McCormack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmet McCormack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmet McCormack more than expected).
Fields of papers citing papers by Emmet McCormack
This network shows the impact of papers produced by Emmet McCormack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmet McCormack. The network helps show where Emmet McCormack may publish in the future.
Co-authors
The 25 scholars most cited alongside Emmet McCormack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Long-term Cultures of Bone Marrow–Derived Human Mesenchymal Stem Cells Frequently Undergo Spontaneous Malignant Transformation Hit paper breakdown → | 2009 | 500 |
| 2 | 2009 | 463 | |
| 3 | A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer Hit paper breakdown → | 2016 | 365 |
| 4 | 2013 | 110 | |
| 5 | 2016 | 98 | |
| 6 | 2013 | 90 | |
| 7 | 2012 | 84 | |
| 8 | 2012 | 81 | |
| 9 | 2013 | 74 | |
| 10 | 2011 | 73 | |
| 11 | 2013 | 61 | |
| 12 | 2005 | 57 | |
| 13 | 2015 | 39 | |
| 14 | 2012 | 38 | |
| 15 | 2008 | 38 | |
| 16 | 2020 | 37 | |
| 17 | 2011 | 36 | |
| 18 | 2015 | 32 | |
| 19 | 2022 | 32 | |
| 20 | 2008 | 31 |
About Emmet McCormack
Emmet McCormack is a scholar working on Molecular Biology, Oncology, Biomedical Engineering, Hematology and Immunology, having authored 92 papers that have together received 3.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (14 papers), Histone Deacetylase Inhibitors Research (11 papers), Cancer Cells and Metastasis (10 papers), Ultrasound and Hyperthermia Applications (9 papers), Protein Degradation and Inhibitors (8 papers), Cancer Research and Treatments (8 papers), Virus-based gene therapy research (6 papers) and Immune Cell Function and Interaction (6 papers). The work is most often cited by research in Genetics (419 citations), Oncology (835 citations), Immunology (529 citations), Cancer Research (361 citations) and Hematology (233 citations). Emmet McCormack has collaborated with scholars based in Norway, United States and Netherlands. Frequent co-authors include Bjørn Tore Gjertsen, Øystein Bruserud, Spiros Kotopoulis, Odd Helge Gilja, Mihaela Popa, David Micklem, James B. Lorens, Rolf Bjerkvig, Georg Dimcevski and Michiel Postema. Their work appears in journals such as PLoS ONE, Blood, Pharmaceutics, Cancers and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.